Skip to main content

Table 2 Survivors and non-survivors

From: Serum sclerostin is an independent predictor of mortality in hemodialysis patients

  Survivors (n = 65) Non-survivors (n = 26)
   All (CV +other causes) CV cause (n = 16) Other causes (n = 10)
Age, years 37.0 ± 13.6 55.4 ± 23.2a 63.0 ± 20.6a 43.3 ± 22.8c
Gender M/F 37/28 18/8 11/5 7/3
Dialysis vintage, mo 132 (48, 180) 84 (63, 105) 96 (48, 126) 72 (60,84)
Diabetes, n 5 9a 7a 2
Hemoglobin, g/dl 11.7 ± 1.5 11.0 ± 1.7 11.4 ± 1.7 10.6 ± 1.6a
Creatinine, mg/dl 11.6 ± 3.3 9.5 ± 2.9a 9.8 ± 2.6a 9.0 ± 3.5a
Albumin, g/dl 4.2 ± 0.4 4.1 ± 0.6 4.1 ± 0.7 4.1 ± 0.5
Ferritin, ng/ml 519 (175, 691) 570 (278, 902) 598 (270, 862) 570 (276,1106)
Calcium, mg/dl 9.1 ± 1.0 9.4 ± 1.3 9.5 ± 1.6 9.4 ± 0.9
Phosphate, mg/dl 5.4 ± 1.9 4.8 ± 1.8 5.3 ± 1.9 3.9 ± 1.3a
AP, U/l 82 (65, 122) 81 (68, 127) 77 (63, 107) 96 (68,158)
PTH, pg/ml 200 (97, 401) 133 (77, 229) 145 (91, 454) 132 (39,180)
Calcitonin, pg/ml 2.8 (2.0,4.9) 3.2 (2.0, 5.7) 2.0 (2.0, 4.82) 4.6 (2.0, 7.6)
β2micro, μg/ml 28 (22, 34) 25 (16, 30) 24 (19, 30) 30 (12, 45)
IL-6, pg/ml 2.8 (1.4, 4.2) 3.3 (2.3, 12.7) 3.0 (2.3, 6.9) 12.7 (2.0, 27.9)a
Klotho, pg/ml 46.8 (7.6, 82.8) 15.7 (0.1, 103.0) 8.7 (0.1, 45.1)b 114.3 (3.7, 167.7)
FGF 23, RU/ml 134 (122, 159) 147 (129, 197)a 150 (129,311)a 143 (133, 152)
Scl, ng/ml 0.76 (0.50, 1.34) 1.45 (0.83, 1.79)a 1.63 (1.20, 1.87)a 0.84 (0.45, 1.73)
  1. M: male; F: female; AP: Alkaline Phosphatase; PTH: parathormone; β2micro: β2microglobulin; IL-6: interleucin; FGF 23: fibroblast growth factor; Scl: sclerostin; ap < 0.05 vs. survivors; bp = 0.052 vs. survivors; cp < 0.05 vs. CV cause.
\